Cargando…
Localisation of clozapine during experimental autoimmune encephalomyelitis and its impact on dopamine and its receptors
Multiple sclerosis is a disease characterised by axonal demyelination in the central nervous system (CNS). The atypical antipsychotic drug clozapine attenuates experimental autoimmune encephalomyelitis (EAE), a mouse model used to study multiple sclerosis, but the precise mechanism is unknown and co...
Autores principales: | Robichon, Katharina, Sondhauss, Sven, Jordan, T. William, Keyzers, Robert A., Connor, Bronwen, La Flamme, Anne C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858600/ https://www.ncbi.nlm.nih.gov/pubmed/33536582 http://dx.doi.org/10.1038/s41598-021-82667-6 |
Ejemplares similares
-
Clozapine reduces infiltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis
por: Robichon, Katharina, et al.
Publicado: (2020) -
Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis
por: Green, Laura K, et al.
Publicado: (2017) -
Amelioration of experimental autoimmune encephalomyelitis by clozapine is not associated with defective CD4 T cell responses
por: Zareie, Pirooz, et al.
Publicado: (2017) -
Treatment with the Antipsychotic Agent, Risperidone, Reduces Disease Severity in Experimental Autoimmune Encephalomyelitis
por: O'Sullivan, David, et al.
Publicado: (2014) -
Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune Encephalomyelitis
por: Ceylan, Ulaş, et al.
Publicado: (2021)